GLP1R and Insulin resistance: In our study, GLP-1 receptor agonists EX and MF significantly improved insulin resistance and endocrine disorder in PCOS, and the average body weight and HOMA-IR of rats in EX group were lower than those in MF group, although the difference was not statistically significant.